Physician Self Disclosure of IUC Use
NCT01994356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2013-11-25
Summary
As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.
Conditions
- Contraception
Interventions
- BEHAVIORAL
-
Physician self-disclosure of personal IUC use
Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling
- BEHAVIORAL
-
Usual contraceptive counseling
all subjects recieved usual contraceptive counseling
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
Inpatient Adolescent Contraception
NCT04423068 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pericoital Oral Contraception With Levonorgestrel
NCT00922233 ·Status: COMPLETED ·Phase: PHASE3
-
IUD Self-Removal Study
NCT05339555 ·Status: COMPLETED ·Phase: NA
-
Study of Birth Control Use After Childbirth
NCT01443533 ·Status: COMPLETED ·Phase: NA
-
HR-QoL and Sexuality in Mirena Inserted Contraception Users
NCT00498784 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Adolescent Adherence to Hormonal Contraception
NCT00584038 ·Status: COMPLETED ·Phase: NA
-
Contraceptive Counseling in the Postpartum Period
NCT02380781 ·Status: COMPLETED ·Phase: NA
-
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962 ·Status: COMPLETED
-
Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)
NCT01181778 ·Status: COMPLETED
-
Implants on Mobile Health Unit
NCT03347539 ·Status: COMPLETED
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of an Intervention to Increase Post-abortion LARC Uptake.
NCT03214848 ·Status: COMPLETED ·Phase: NA
-
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
NCT04112095 ·Status: COMPLETED ·Phase: PHASE3
-
Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction
NCT02752282 ·Status: UNKNOWN ·Phase: NA
-
Video Versus Conversational Contraceptive Counseling During Maternity Hospitalization
NCT03400449 ·Status: COMPLETED ·Phase: NA
-
Quick Start Insertion of Mirena and ParaGard
NCT01730911 ·Status: COMPLETED ·Phase: NA
-
Study on Medical Records of Women Using an Intrauterine Device (IUD) to Analyze the Risks That the IUD Will be Expelled or Perforates the Womb in Relation to Breastfeeding, the Point in Time When the IUD Was Inserted After Childbirth and in Relation to Different Types of IUDs
NCT03754556 ·Status: COMPLETED
-
Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population
NCT03486743 ·Status: COMPLETED ·Phase: NA
-
Telemedicine for Contraceptive Counselling- An Open Randomized Controlled Trial
NCT06896539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training
NCT01360216 ·Status: COMPLETED ·Phase: NA
-
A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)
NCT03230539 ·Status: UNKNOWN ·Phase: PHASE1
-
Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial
NCT00653159 ·Status: COMPLETED ·Phase: PHASE4
-
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771 ·Status: COMPLETED
-
Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
NCT01805817 ·Status: WITHDRAWN ·Phase: PHASE4
-
EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT
NCT02293213 ·Status: COMPLETED ·Phase: NA